InsightfulValue
← Home

GlaxoSmithKline
GlaxoSmithKline

Pharma / Pharma and biotechnology


Financial Growth

Pay attention and research significant changes from year to year values. [ ! ]

Fixed ColumnRevenue GrowthGross Profit GrowthEBIT GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share GrowthOperating Cash Flow GrowthFree Cash Flow GrowthTen Y Revenue Growth Per ShareFive Y Revenue Growth Per ShareThree Y Revenue Growth Per ShareTen Y Operating CF Growth Per ShareFive Y Operating CF Growth Per ShareThree Y Operating CF Growth Per ShareTen Y Net Income Growth Per ShareFive Y Net Income Growth Per ShareThree Y Net Income Growth Per ShareTen Y Shareholders Equity Growth Per ShareFive Y Shareholders Equity Growth Per ShareThree Y Shareholders Equity Growth Per ShareTen Y Dividend per Share Growth Per ShareFive Y Dividend per Share Growth Per ShareThree Y Dividend per Share Growth Per ShareReceivables GrowthInventory GrowthAsset GrowthBook Value per Share GrowthDebt GrowthR&D Expense GrowthSGA Expenses Growth
2024-120.03450.0259-0.4038-0.4038-0.4774-0.4836-0.48330.00690.00720.0802-0.0316-0.19250.2857-0.0983-0.2780.1937-0.2073-0.353-0.1191-0.4622-0.5392.02320.1065-0.2872-0.4004-0.4002-0.5203-1.00.03110.00770.0157-0.05720.02860.1736
2023-120.03420.10080.04840.04840.00140.00.00.00640.0066-0.356-0.0857-0.14010.0913-0.0453-0.1262-0.1061-0.2202-0.2122-0.13530.3196-0.15780.81941.9699-0.101-0.4176-0.4448-0.44490.0830.0684-0.01890.2592-0.14140.13390.1209
2022-12-0.1404-0.12170.03740.03740.1222-0.1094-0.11110.25710.2598-0.3103-0.0690.02460.0828-0.0568-0.1460.65150.0389-0.09260.05212.11860.04140.7804152.3159-0.1306-0.1127-0.1382-0.1378-0.1271-0.1101-0.2396-0.6237-0.13170.0397-0.2371
2021-124.0E-40.0051-0.2032-0.2032-0.2372-0.0486-0.0559-0.1955-0.19570.2499-0.0579-0.19040.56450.4850.35870.59810.48590.15920.04694.83740.48571.354315.26163.23880.47470.0010.250.1256-0.0355-0.01650.2749-0.10960.0353-0.0419
2020-12****************************************************************************************************************************************
2019-12****************************************************************************************************************************************
2018-12****************************************************************************************************************************************
2017-12****************************************************************************************************************************************
2016-12****************************************************************************************************************************************
2015-12****************************************************************************************************************************************
2014-12****************************************************************************************************************************************
GlaxoSmithKline

Explore more financial growth data for GlaxoSmithKline!

Sign up for free or log in
© 2024 - 2025 InsightfulValue.com. All rights reserved. Legal